8 Regional Consumables Alliance Procurement Results Announced

1

Purchasing by Henan Union has dropped by as much as 94%

On May 11, the Xinxiang Medical Security Bureau of Henan Province announced the results of the centralized procurement of medical consumables (reagents) alliances in eight cities (counties) including Xinxiang City, Henan Province.

This purchase includes medical consumables such as disposable central venous catheters, disposable high-pressure contrast syringes and accessories (packages), disposable ventilator tubing gas packages, creatinine detection reagents, homocysteine ​​detection reagents and other reagents product.

The selected machinery companies include Henan Camel, Shenzhen Ante, Shenzhen Mindray, Meikang Biological, Guangdong Baihe, Ali Biotech, Neusoft Wetman, Nine Strong Biological, Mike Biological and other mechanical companies.

On November 6, 2020, the Centralized Procurement Platform for Medicines and Medical Consumables in Xinxiang City, Henan Province issued the "Notice on Doing a Good Job in Filling in Information Related to the Centralized Procurement of Medical Consumables Alliance in Eight Cities (Counties) including Xinxiang City".

This is the second municipal volume procurement alliance that has emerged in Henan Province.

On October 28, 2020, according to Dahe.

According to the relevant person in charge of the Henan Provincial Medical Insurance Bureau, "the first centralized procurement quantity accounts for 70%-80% of the total use of these two types of medical consumables in medical institutions in the province, and the procurement volume of selected products is directly clarified to each medical institution.

2

Controversy over testing reagents, beacon smoke everywhere

We have seen that in the centralized procurement of the eight cities of Xinxiang Medical Consumables Alliance, a total of 18 companies for homocysteine ​​testing reagents have been selected, among which Top Nine Biology, Mike Biology, and Shenzhen Mindray are among the market leaders.

At present, the domestic biochemical diagnostic market share of reagents produced in China has exceeded 50%.

Top Nine Bio: The company released its first quarterly report for 2021, and achieved operating income of RMB 374 million, an increase of 231.

In the 2020 annual report, due to the impact of the import of foreign epidemics and the rebound of local epidemics throughout the country, the normal diagnosis and treatment work of medical institutions is subject to certain restrictions, and the terminal demand for biochemical diagnostic reagents is affected to a certain extent.

Shenzhen Mindray:

Shenzhen Mindray’s in vitro diagnostic revenue in 2015 was 2.

Mindray has a market share of 10% in the domestic biochemical diagnostics market in 2019, second only to Beckman and Roche.

Mike Biology:

Mike Biology performed well in the full year of 2020 and the first quarter of 2021.

Regardless of whether it is the top nine, Mike or Mindray, the diagnostic consumables business is the pillar business of the enterprise.